IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Svennilson Peter

Q2 2019 Holdings

Filed 2019-08-14 | 8 holdings | $28.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$28.2M3,540,85098.9%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$229.8K15,694,0910.8%
Constellation Pharmceticls I(CNST)COM210373106$57.4K4,677,9390.2%
Gritstone Oncology Inc(2JQ)COM39868T105$34.6K3,102,9340.1%